The possible roles of perceptual characteristics (colour, shape, size) of tablets and personality characteristics in generating expectations of drug side effects were investigated. Two hundred and thirteen hospitalized patients (mean age 48.9 ± 18.84 years) completed questionnaires (trait anxiety — STAI-T, dispositional optimism — LOT-R, subjective somatic symptoms — PHQ-15, somatosensory amplification — SSAS, previous personal and family-level experiences) and the expected probabilities of nine side effects for six differently looking tablets were estimated. PHQ-15, SSAS and family-level experience scores were significant predictors of the expectations of side effects. Red tablets evoked significantly more stimulating type expectations than did white pills. Expected gastrointestinal side effects were associated with oblong-shaped tablets. Regarding headache, medium-sized round tablet was expected to evoke fewer side effects than the small round and the oblong tablets. Although expectations do not always manifest themselves as actual symptoms, they can reduce the overall effectiveness of a therapy by influencing patient's adherence.
. S. C. Shea 2006 Improving Medication Adherence Lippincott Williams & Wilkins Philadelphia.
. L. W. Buckalew R. E. Sallis 1986 Patient compliance and medication perception J. Clin. Psychol. 42 49–53.
. F. Köteles Gy. Bárdos 2009 Expectations of side effects evoked by perceptual characteristics of curatives and their psychological background Mentálhigiéné és Pszichoszomatika 10 47–62.
. A. J. de Craen P. J. Roos A. L. de Vries J. Keijnen 1996 Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness BMJ 313 1624–1626.
. F. Köteles Gy. Bárdos 2007 Expectations of drug effects based on colour and size of tablets Mentálhigiéné és Pszichoszomatika 8 277–290.
. L. W. Buckalew K. E. Coffield 1982 An investigation of drug expectancy as a function of capsule colour, size, and preparation form J. Clin. Psychopharmacol. 2 245–248.
. A. J. Barsky R. Saintfort M. P. Rogers J. Borus 2002 Nonspecific medication side effects and the nocebo phenomenon JAMA 287 622–627.
. R. R. Bootzin E. T. Bailey 2005 Understanding placebo, nocebo, and iatrogenic treatment effects J. Clin. Psychol. 61 871–880.
. A. J. Barsky J. D. Goodson R. S. Lane P. D. Cleary 1988 The amplification of somatic symptoms Psychosom. Med. 50 510–519.
. C. Davis E. Ralevski S. Kennedy C. Neitzert 1995 The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers J. Clin. Psychopharmacol. 15 347–352.
. A. L. Geers S. G. Helfer K. Kosbab P. Weiland S. J. Landry 2005 Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response J. Psychosom. Res. 58 121–127.
. F. Köteles Gy. Bárdos 2011 What makes us sicker? An experimental study of non-specific adverse drug effects Clin. Exp. Med. J. 5 203–215.
. C. D. Spielberger R. L. Gorsuch R. E. Lushene 1970 Manual for the State-Trait Anxiety Inventory Consulting Psychologists Press Palo Alto, CA.
. K. Kroenke R. L. Spitzer J. B. Williams 2002 The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms Psychosom. Med. 64 258–266.
. A. J. Barsky G. Wyshak G. L. Klerman 1990 The Somatosensory Amplification Scale and its relationship to hypochondriasis J. Psychiatr. Res. 24 323–334.
. M. F. Scheier C. S. Carver M. W. Bridges 1994 Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test J. Pers. Soc. Psychol. 67 1063–1078.
|Clinical and Experimental Medical Journal|
|H-1117 Budapest, Hungary 1516 Budapest, PO Box 245|
|Chief Executive Officer, Akadémiai Kiadó|
|Abstract Views||Full Text Views||PDF Downloads|